ConductScience.org, home

Paper2145367

The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.

Gooding LR and 4 others. J Immunol, 1990. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. Papers, record 2145367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2145367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.
PubMed
Journal
J Immunol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2014-11-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gooding LRL R
2Sofola IOI O
3Tollefson AEA E
4Duerksen-Hughes PP
5Wold WSW S

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenoviruses, HumanMajor topic
Cell SurvivalMajor topic
Oncogene Proteins, ViralMajor topic
Tumor Necrosis Factor-alphaMajor topic
Actin Cytoskeleton
Adenovirus Early Proteins
Animals
Cell Line
Cycloheximide
Cytochalasins
In Vitro Techniques
Mice
Molecular Weight

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA24710NCI NIH HHSUnited StatesR01CA024710PubMed and NIHNIH RePORTER
CA40266NCI NIH HHSUnited StatesR01CA040266PubMed and NIHNIH RePORTER
CA48219NCI NIH HHSUnited StatesR01CA048219PubMed and NIHNIH RePORTER
R23CA024710NIHNIH RePORTER

Download CSV of grants

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
42558152Adenoviral E3/49K: CD45-targeted immune evasion and therapeutic potential.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42558152PubMed
36851572A Renaissance for Oncolytic Adenoviruses?Viruses2023https://conductscience.org/library/papers/36851572PubMed
34549981Biographical Feature: William S. M. Wold, Ph.D., 1944-2021.J Virol2021https://conductscience.org/library/papers/34549981PubMed
30046247Pathogenesis and management of adenoviral keratoconjunctivitis.Infect Drug Resist2018https://conductscience.org/library/papers/30046247PubMed
29875767Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.Front Immunol2018https://conductscience.org/library/papers/29875767PubMed
28899926Peptides mediating DNA transport on microtubules and their impact on non-viral gene transfer efficiency.Biosci Rep2017https://conductscience.org/library/papers/28899926PubMed
28122980Suppression of Type I Interferon Signaling by E1A via RuvBL1/Pontin.J Virol2017https://conductscience.org/library/papers/28122980PubMed
24027303Homologous recombination in E3 genes of human adenovirus species D.J Virol2013https://conductscience.org/library/papers/24027303PubMed
22675546E3-14.7K is recruited to TNF-receptor 1 and blocks TNF cytolysis independent from interaction with optineurin.PLoS One2012https://conductscience.org/library/papers/22675546PubMed
21976655The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.J Virol2011https://conductscience.org/library/papers/21976655PubMed
21142450Interference with intraepithelial TNF-α signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infection.Viral Immunol2010https://conductscience.org/library/papers/21142450PubMed
18461366Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.J Cancer Res Clin Oncol2008https://conductscience.org/library/papers/18461366PubMed
17494079Investigation of adenovirus occurrence in pediatric tumor entities.J Virol2007https://conductscience.org/library/papers/17494079PubMed
17139321Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver.Cancer Gene Ther2007https://conductscience.org/library/papers/17139321PubMed
17024246Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism.J Clin Invest2006https://conductscience.org/library/papers/17024246PubMed
16775326Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.J Virol2006https://conductscience.org/library/papers/16775326PubMed
16227281Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex.J Virol2005https://conductscience.org/library/papers/16227281PubMed
15920462Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.Gene Ther2005https://conductscience.org/library/papers/15920462PubMed
15542663Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1.J Virol2004https://conductscience.org/library/papers/15542663PubMed
12502827The adenovirus e3 promoter is sensitive to activation signals in human T cells.J Virol2003https://conductscience.org/library/papers/12502827PubMed

See all 48 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2145367

GET https://conductscience.org/api/papers/v1/2145367/cited_by?page=2